NCT04818203View on ClinicalTrials.gov

A Study on the Anti-Wrinkle Efficacy Assessment and Safety Evaluation of the Cluster of Autologous Dermal Fibroblast on Bilateral Crow's Feet

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 20, 2020

Primary Completion Date

July 5, 2025

Study Completion Date

June 30, 2026

Conditions
Crow's Feet
Interventions
BIOLOGICAL

Clusters of Autologous Dermal Fibroblasts

Dose: 1 x 10\^7 cells/1 mL/vial

OTHER

Placebo

The injection solution without clusters of autologous dermal fibroblasts

Trial Locations (1)

156-755

RECRUITING

Chung-Ang University Hospital, Seoul

All Listed Sponsors
collaborator

Dt&Sanomedics

INDUSTRY

lead

S.Biomedics Co., Ltd.

INDUSTRY